Augmentation of restless legs syndrome (RLS) under rotigotine: Results from a 5-year prospective, multinational, open-label study

被引：0
|
作者：
Kohnen, R.
Garcia-Borreguero, D.
Benes, H.
Ferini-Strambi, L.
Hoegl, B.
Oertel, W.
Trenkwalder, C.
Fichtner, A.
Schollmayer, E.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1086
引用
收藏
页码：S361 / S361
页数：1
相关论文
共 50 条
  • [1] Augmentation of Restless Legs Syndrome (RLS) under Rotigotine: Results from a 5-Year Prospective, Multinational, Open-Label Study
    Garcia-Borreguero, Diego
    Benes, Heike
    Ferini-Strambi, Luigi
    Hoegl, Birgit
    Oertel, Wolfgang
    Trenkwalder, Claudia
    Fichtner, Andreas
    Schollmayer, Erwin
    Kohnen, Ralf
    NEUROLOGY, 2011, 76 (09) : A370 - A370
  • [2] RELATIONSHIP BETWEEN CLINICALLY SIGNIFICANT AUGMENTATION OF RESTLESS LEGS SYNDROME (RLS) AND DOSAGE OF ROTIGOTINE TRANSDERMAL SYSTEM: POST HOC ANALYSIS OF A 5-YEAR PROSPECTIVE, MULTINATIONAL, OPEN-LABEL STUDY
    Kohnen, R.
    Benes, H.
    Strambi, Ferini L.
    Hogl, B.
    Oertel, W.
    Trenkwalder, C.
    Fichtner, A.
    Schollmayer, E.
    Garcia-Borreguero, D.
    SLEEP, 2011, 34 : A200 - A200
  • [3] Long-Term Safety and Efficacy of Rotigotine in Patients with Idiopathic RLS: 5-Year Results from a Prospective Multinational Open-Label FollowUp Study
    Hogl, Birgit
    Trenkwalder, Claudia
    Garcia-Borreguero, Diego
    Kohnen, Ralf
    Poewe, Werner
    Stiasny-Kolster, Karin
    Bauer, Lars
    Fichtner, Andreas
    Schollmayer, Erwin
    Oertel, Wolgang
    NEUROLOGY, 2010, 74 (09) : A106 - A106
  • [4] Long-term safety and efficacy of rotigotine in patients with idiopathic RLS: 5-year results front a prospective multinational open-label follow-up study
    Hogl, I.
    Trenkwalder, C.
    Garcia-Borreguero, D.
    Kohnen, R.
    Poewe, W.
    Stiasny-Kolster, K.
    Bauer, L.
    Fichtner, A.
    Schollmayer, E.
    Oertel, W.
    MOVEMENT DISORDERS, 2010, 25 (07) : S517 - S517
  • [5] An open label study of oxcarbazepine in Restless Legs Syndrome (RLS)
    Youssef, IS
    Walters, AS
    SLEEP, 2004, 27 : 292 - 292
  • [6] Improvements in daytime symptoms in patients with restless legs syndrome - 24 months results from a multinational, open-label trial with the rotigotine transdermal system
    Oertel, Wolfgang H.
    Stiasny-Kolster, Karin
    Garcia-Borreguero, Diego
    Poewe, Werner
    Hoegl, Birgit
    Kohnen, Ralf
    Schollmayer, Ervin
    Keffel, Joerg
    Trenkwalder, Claudia
    ANNALS OF NEUROLOGY, 2007, 62 : S39 - S40
  • [7] Tolerability and efficacy of ropinirole in patients with intermittent restless legs syndrome (RLS): Open-label results
    Black, J.
    Merchant, K.
    MOVEMENT DISORDERS, 2006, 21 (09) : 1554 - 1554
  • [8] Ropinirole for restless legs syndrome (RLS): An open-label and double blind placebo controlled study
    Freeman, A
    Rye, DB
    Bliwise, D
    Chakravorty, S
    Krulewicz, S
    Watts, RL
    NEUROLOGY, 2001, 56 (08) : A5 - A5
  • [9] Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
    Oertel, Wolfgang
    Trenkwalder, Claudia
    Benes, Heike
    Ferini-Strambi, Luigi
    Hoegl, Birgit
    Poewe, Werner
    Stiasny-Kolster, Karin
    Fichtner, Andreas
    Schollmayer, Erwin
    Kohnen, Ralf
    Garcia-Borreguero, Diego
    LANCET NEUROLOGY, 2011, 10 (08): : 710 - 720
  • [10] LONG-TERM TREATMENT WITH TRANSDERMAL ROTIGOTINE IN PATIENTS WITH IDIOPATHIC RESTLESS LEGS SYNDROME (RLS): RESULTS FROM A 12-MONTH OPEN-LABEL EXTENSION TRIAL
    Allen, R. P.
    Winkelman, J.
    Ondo, W.
    Fichtner, A.
    Schollmayer, E.
    SLEEP, 2010, 33 : A251 - A251
12345